Ozempic is the injectable peptide GLP-1 medicine with the most FDA-approved uses in type 2 diabetes, with indications to improve blood sugar along with diet and exercise, to reduce the risk of major cardiovascular events (heart attack, stroke, or death) in adults who also have known heart disease, and to reduce the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease.1 Ozempic injection and Ozempic tablets are not approved for use in children
J 2020, 26 (20), 44764479
In addition, miR-486 was shown to have a potent tumor suppressor role in NSCLC through direct targeting of IGF-1R as well as IGF-1 (Peng et al., 2013)
3 Rapid eye movement sleep behavior disorder (RBD) represents the most specific prodromal marker of PD, conferring over 90% risk of phenoconversion to -synucleinopathies, predominantly PD, over a 14-year follow-up period